Venetian Resort Las Vegas

The Venetian Theatre


This 1800-seat theatre was designed specifically to house a special production of Andrew Lloyd Webber’s Phantom of the Opera.

As described by USA TODAY, “Rebranded Phantom: The Las Vegas Spectacular- will occur in an 1,800-seat playhouse designed to look like the 19th-century Opera Garnier in Paris. Because the narrative starts in a ruined opera house, the audience first sees the chandelier askew and huge canvas draping the walls. When the tale flashes back, the canvas flies off, and the chandelier pieces assemble and light up in an 80-foot-wide dome.” – Steve Friess

Working closely with the Venetian Resort Hotel Casino, and Live Nation (Clear Channel’s theatrical productions offshoot) FDA and the Rockwell Group created an 1800 seat horseshoe “opera house” on a minimal site between the existing Venetian Casino and the Venezia Tower. While the public will be awed by the opulent “set”, equal attention was given to the back of house layouts. Since this space was specially built for this show, it will run ten times a week (requiring multiple casts and other special accommodations for this perennially popular production).

  • Client: Venetian Resort Hotel Casino
  • Architect: The Rockwell Group
  • Arch. of Record: Leo Daly
  • Completion Year: 2006
  • Location: Las Vegas, Nevada
  • Acoustician: PMK
  • Capacity: 1,800 seats

Links
Privacy Settings
We use cookies to enhance your experience while using our website. If you are using our Services via a browser you can restrict, block or remove cookies through your web browser settings. We also use content and scripts from third parties that may use tracking technologies. You can selectively provide your consent below to allow such third party embeds. For complete information about the cookies we use, data we collect and how we process them, please check our Privacy Policy
Youtube
Consent to display content from - Youtube
Vimeo
Consent to display content from - Vimeo
Google Maps
Consent to display content from - Google
error: Content is protected. Please reach out to rhackman@fda-online.com for any materials needed. Thank you